EU regulators gear up for pharma reform as generics warn of new burdens
The EU is finalizing a major overhaul of its pharmaceutical rules. While generic drugmakers welcome steps that could speed up market entry, they warn that new supply requirements and procedural changes...To view the full article, register now.
Already a subscriber? Click here to view full article